DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 215 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,280,772 | +8.9% | 183,785 | +22.6% | 0.00% | 0.0% |
| Q4 2023 | $2,095,141 | +178.7% | 149,867 | +95.6% | 0.00% | +33.3% |
| Q1 2023 | $751,623 | -70.0% | 76,618 | -67.5% | 0.00% | -76.9% |
| Q4 2022 | $2,506,922 | +741.2% | 235,613 | +758.0% | 0.01% | +333.3% |
| Q1 2022 | $298,000 | -38.9% | 27,462 | -75.7% | 0.00% | -57.1% |
| Q3 2020 | $488,000 | – | 112,859 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
| DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
| Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
| PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
| Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
| Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
| Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
| Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |